TRVLX
Price
$53.60
Change
+$0.45 (+0.85%)
Updated
Jun 2 closing price
Net Assets
33.31B
VIVAX
Price
$83.19
Change
+$0.71 (+0.86%)
Updated
Jun 2 closing price
Net Assets
237.83B
Interact to see
Advertisement

TRVLX vs VIVAX

Header iconTRVLX vs VIVAX Comparison
Open Charts TRVLX vs VIVAXBanner chart's image
TRVLX vs VIVAX Comparison Chart in %
View a ticker or compare two or three
VS
TRVLX vs. VIVAX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TRVLX is a StrongBuy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 238B vs. TRVLX (33.3B). VIVAX pays higher dividends than TRVLX: VIVAX (1.76) vs TRVLX (0.82). TRVLX was incepted earlier than VIVAX: TRVLX (32 years) vs VIVAX (34 years). TRVLX (0.72) is less costly to investors than VIVAX (0.17). TRVLX is a more actively managed with annual turnover of: 59.50 vs. VIVAX (8.00). VIVAX has a lower initial minimum investment than TRVLX: VIVAX (0) vs TRVLX (2500). VIVAX annual gain was more profitable for investors over the last year : 23.23 vs. TRVLX (15.72). VIVAX return over 5 years is better than : 50.69 vs. TRVLX (13.88).
TRVLXVIVAXTRVLX / VIVAX
Total Expense Ratio0.710.17418%
Annual Report Gross Expense Ratio0.720.17424%
Fund Existence32 years34 years-
Gain YTD11.10010.667104%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets33.3B238B14%
Annual Yield % from dividends0.821.7647%
Returns for 1 year15.7223.2368%
Returns for 3 years41.4753.1678%
Returns for 5 years13.8850.6927%
Returns for 10 years84.16150.4356%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SBACX31.24N/A
N/A
Touchstone Balanced C
COFYX44.14N/A
N/A
Columbia Contrarian Core Inst3
SPSAX21.97N/A
N/A
Sterling Capital Behav Sm Cp Val Eq A
EMEAX19.39N/A
N/A
Ashmore Emerging Markets Equity A
BMSLX16.74N/A
N/A
MFS Blended Research Mid Cap Eq I